Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890415) titled 'Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Malignant Melanoma of Skin
Other and Unspecified Malignant Neoplasm of Skin
Melanoma in Situ
Carcinoma in Situ of Skin
Hemangioma
Melanocytic Nevi
Other Benign Neoplasms of Skin
Neoplasm of Uncertain Behavior of Skin
Neoplasm of Uncertain Behavior, Unspecified
Neoplasm of Unspecified Behavior of Bone, Soft...